Background illustration for clinical trials search

Kidney Disease Clinical Trials

Browse 1,106 Kidney Disease clinical trials enrolling across the United States and Canada. 69 people applied to Kidney Disease studies last month. Search by city or state to find one near you.

Filter
1

Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

for
Urinary Tract Infection, Recurrent
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Female

Age: 18+

Code: NCT06409819

Phase 1, Phase 2, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

for
B-NHL, B-Non Hodgkin Lymphoma, Acute Lymphocytic Leukemia,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 39

Code: NCT05442515

Phase 1, Phase 2, Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Boston MA, Charleston SC, Toronto, Atlanta GA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD, Nashville TN, Chicago IL, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0+

Code: NCT04195633

Phase 2, Recruiting

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

for
B Cell Acute Lymphoblastic Leukemia (B-ALL),
Location: Philadelphia PA
Sponsor: Stephan Grupp MD PhD

Sex: All

Age: 0 - 29

Code: NCT05480449

Phase 1, Phase 2, Recruiting

Noninvasive Spinal Cord Stimulation for Early SCI

for
Spinal Cord Injuries, Bowel Dysfunction, Sexual Dysfunction,
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19 - 65

Code: NCT06587841

Recruiting

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

for
Non-Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma (B-NHL),
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 16+

Code: NCT05098613

Phase 1, Recruiting

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01746836

Phase 2, Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Buffalo NY, Chicago IL
Sponsor: Marlise Luskin, MD

Sex: All

Age: 18+

Code: NCT03595917

Phase 1, Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: New York NY, Richmond VA, Toronto, Tampa FL, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137118

Phase 1, Phase 2, Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

for
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 65

Code: NCT02115295

Phase 2, Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

for
Acute Leukemia of Ambiguous Lineage,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 65

Code: NCT06013423

Phase 2, Recruiting

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

for
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL),
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT04186520

Phase 1, Phase 2, Recruiting

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

for
Osteoarthritis, Knee, Osteoarthritis, Hip,
Location: Palo Alto CA
Sponsor: Palo Alto Veterans Institute for Research

Sex: All

Age: 25 - 70+

Code: NCT05700682

Recruiting

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03263572

Phase 2, Recruiting

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Miami FL
Sponsor: Florida International University

Sex: All

Age: 0 - 21

Code: NCT05857969

Phase 1, Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

for
Hematologic Malignancy, Leukemia, Lymphoma,
Location: Philadelphia PA, Cincinnati OH, Milwaukee WI,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 38

Code: NCT06131801

Recruiting

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT03589729

Phase 2, Recruiting

What are clinical trials for kidney disease?

Clinical trials for kidney disease are research studies designed to test new treatments, interventions, or diagnostic methods aimed at improving the management and outcomes of kidney conditions including kidney disease. These trials may involve experimental medications, innovative therapies, surgical techniques, or lifestyle interventions.

The importance of kidney disease clinical trials

Kidney disease clinical trials are crucial because they help advance our understanding of kidney disorders so that more effective treatments can be developed. These trials test new drugs, therapies, and diagnostic methods, aiming to improve patient outcomes, slow disease progression, and enhance quality of life.

Clinical trials for kidney disease also provide valuable data on the safety and efficacy of new interventions, which can lead to better management strategies and potential cures. Without clinical trials, the development of innovative solutions and improvements in care for kidney disease would be limited, potentially leaving patients with fewer options and suboptimal outcomes.

Types of kidney disease clinical trials

Participation in a clinical trial for kidney disease

Who can take part in a kidney disease clinical trial?

How to enroll in a clinical trial for kidney disease